Waldencast PLC (NASDAQ:WALD – Get Free Report) saw a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling 987,500 shares, a drop of 29.0% from the September 15th total of 1,390,000 shares. Currently, 5.5% of the shares of the stock are sold short. Based on an average trading volume of 247,500 shares, the days-to-cover ratio is currently 4.0 days. Based on an average trading volume of 247,500 shares, the days-to-cover ratio is currently 4.0 days. Currently, 5.5% of the shares of the stock are sold short.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Waldencast in a report on Friday. Telsey Advisory Group cut their price objective on Waldencast from $4.00 to $3.00 and set an “outperform” rating for the company in a report on Wednesday, August 20th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Waldencast currently has an average rating of “Moderate Buy” and an average price target of $4.97.
Read Our Latest Report on Waldencast
Hedge Funds Weigh In On Waldencast
Waldencast Price Performance
Shares of NASDAQ:WALD opened at $1.92 on Friday. Waldencast has a 1-year low of $1.48 and a 1-year high of $4.18. The business has a 50-day moving average price of $1.84 and a two-hundred day moving average price of $2.21.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Stories
- Five stocks we like better than Waldencast
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How Technical Indicators Can Help You Find Oversold Stocks
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- What to Know About Investing in Penny Stocks
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
